DISEASE INDICATIONS: Thromboembolism
MANUFACTURER: Alexion Pharmaceuticals
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Andexxa, with its generic name coagulation factor Xa (recombinant), inactivated-zhzo, is a specialized medication used in the field of hematology and coagulation medicine. It is primarily designed to address life-threatening bleeding events or complications associated with the use of certain anticoagulant medications, specifically direct or indirect factor Xa inhibitors.
